The burgeoning landscape of innovative treatments for body management has seen the rise of both retatrutide and tirzepatide, both dual mechanism agonists targeting the GLP-1 and GIP receptors. While sharing a similar https://honeycord907131.nico-wiki.com/2002170/retatrutide_vs_tirzepatide_a_comparative_analysis